Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Cash from Operations: 2010-2025

Historic Cash from Operations for Mesa Laboratories (MLAB) over the last 16 years, with Sep 2025 value amounting to $8.2 million.

  • Mesa Laboratories' Cash from Operations rose 55.99% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.9 million, marking a year-over-year increase of 1.18%. This contributed to the annual value of $46.8 million for FY2025, which is 6.06% up from last year.
  • Mesa Laboratories' Cash from Operations amounted to $8.2 million in Q3 2025, which was up 334.34% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Mesa Laboratories' Cash from Operations ranged from a high of $18.1 million in Q4 2024 and a low of -$2.8 million during Q2 2022.
  • Moreover, its 3-year median value for Cash from Operations was $10.7 million (2024), whereas its average is $10.3 million.
  • As far as peak fluctuations go, Mesa Laboratories' Cash from Operations plummeted by 129.31% in 2022, and later skyrocketed by 453.58% in 2023.
  • Over the past 5 years, Mesa Laboratories' Cash from Operations (Quarterly) stood at $15.9 million in 2021, then tumbled by 51.45% to $7.7 million in 2022, then spiked by 49.46% to $11.5 million in 2023, then surged by 57.17% to $18.1 million in 2024, then skyrocketed by 55.99% to $8.2 million in 2025.
  • Its last three reported values are $8.2 million in Q3 2025, $1.9 million for Q2 2025, and $12.7 million during Q1 2025.